Cargando…

Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells

BACKGROUND: Human CD133+ hematopoietic progenitor cells (HPCs) are a specific subset of cells that can regulate tumor malignancy. However, the mechanism by which CD133+ HPCs affect the malignancy of human breast cancer has not been reported. METHODS: CD133+ HPCs were isolated and purified from human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhe, Zheng, Qinglian, Liu, Yonghui, Sun, Lianqing, Han, Pingping, Wang, Rui, Zhao, Jiao, Hu, Shan, Zhao, Xinhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690192/ https://www.ncbi.nlm.nih.gov/pubmed/33243165 http://dx.doi.org/10.1186/s12885-020-07633-3

Ejemplares similares

Effects of VEGFR1(+) hematopoietic progenitor cells on pre-metastatic niche formation and in vivo metastasis of breast cancer cells
por: Meng, Du, et al.
Publicado: (2018)

Detection of the Hematopoietic Stem and Progenitor Cell Marker CD133 during Angiogenesis in Three-Dimensional Collagen Gel Culture
por: Akita, Masumi, et al.
Publicado: (2013)

Proteasomes Are Critical for Maintenance of CD133+CD24+ Kidney Progenitor Cells
por: Al-Marsoummi, Sarmad, et al.
Publicado: (2023)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Mobilization of CD133(+) Progenitor Cells in Patients with Acute Cerebral Infarction
por: Sepp, Dominik, et al.
Publicado: (2014)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Combined Characterization of microRNA and mRNA Profiles Delineates Early Differentiation Pathways of CD133(+) and CD34(+) Hematopoietic Stem and Progenitor Cells
por: Bissels, Ute, et al.
Publicado: (2011)

Role of progenitor cell marker CD133 in supporting diagnosis of collapsing glomerulopathy
por: Xiao, Andrew Y., et al.
Publicado: (2022)

Cross Talk with Hematopoietic Cells Regulates the Endothelial Progenitor Cell Differentiation of CD34 Positive Cells
por: Kwon, Sang-Mo, et al.
Publicado: (2014)

THE CD133-POSITIVE COLON CANCER CELL PHENOTYPE IS MORE INTERACTIVE WITH THE TUMOR MICROENVIRONMENT COMPARED TO CD133-NEGATIVE CELL
por: Chao, Celia, et al.
Publicado: (2011)

The CD133(+) Stem/Progenitor-Like Cell Subset Is Increased in Human Milk and Peripheral Blood of HIV-Positive Women
por: Valverde-Villegas, Jacqueline María, et al.
Publicado: (2020)

Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer
por: Okamoto, Oswaldo Keith, et al.
Publicado: (2007)

All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis
por: Mei, Dan, et al.
Publicado: (2017)

A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cells()
por: Pepperell, Emma E., et al.
Publicado: (2013)

GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy
por: Gaipa, Giuseppe, et al.
Publicado: (2010)

CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells
por: Takahashi, M, et al.
Publicado: (2014)

CD11a regulates hematopoietic stem and progenitor cells
por: Hou, Lifei, et al.
Publicado: (2023)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
por: Marques Jr, José Francisco Comenalli
Publicado: (2011)

Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis
por: Varricchio, Lilian, et al.
Publicado: (2022)

Human Hepatic Progenitor Cells Express Hematopoietic Cell Markers CD45 and CD109
por: Li, Jun, et al.
Publicado: (2013)

Expansion of CD133(+) Umbilical Cord Blood Derived Hematopoietic Stem Cells on a Biocompatible Microwells
por: Soufizomorrod, Mina, et al.
Publicado: (2013)

Transient loading of CD34(+) hematopoietic progenitor cells with polystyrene nanoparticles
por: Deville, Sarah, et al.
Publicado: (2017)

CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
por: Nonino, A., et al.
Publicado: (2018)

Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells
por: Lu, Ruiqi, et al.
Publicado: (2019)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

CD133-Positive Cells Might Be Responsible for Efficient Proliferation of Human Meningioma Cells
por: Tang, Hailiang, et al.
Publicado: (2012)

CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
por: Tsunekuni, Kenta, et al.
Publicado: (2019)

Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients
por: Bogoslovsky, Tanya, et al.
Publicado: (2011)

Identification of CD133-Positive Radioresistant Cells in Atypical Teratoid/ Rhabdoid Tumor
por: Chiou, Shih-Hwa, et al.
Publicado: (2008)

DNA Damage in CD133-Positive Cells in Barrett's Esophagus and Esophageal Adenocarcinoma
por: Thanan, Raynoo, et al.
Publicado: (2016)

Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma
por: Hou, Ya-Chin, et al.
Publicado: (2014)

Isolation and characteristics of CD133(−)/A2B5(+) and CD133(−)/A2B5(−) cells from the SHG139s cell line
por: HAN, YONG, et al.
Publicado: (2015)

MicroRNA Microarray Profiling during Megakaryocyte Differentiation of Cord Blood CD133+ Hematopoietic Stem Cells
por: Houshmand, Mohammad, et al.
Publicado: (2018)

Identification of a CD133−CD55− population functions as a fetal common skeletal progenitor
por: Weng, Lihong, et al.
Publicado: (2016)

CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients
por: Gójska-Grymajło, Anna, et al.
Publicado: (2018)

Elevated glucose represses lysosomal and mTOR-related genes in renal epithelial cells composed of progenitor CD133(+) cells
por: Shrestha, Swojani, et al.
Publicado: (2021)

Malignant behaviorial characteristics of CD133(+/−) glioblastoma cells from a Northern Chinese population
por: LIU, XIAOZHI, et al.
Publicado: (2013)

CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
por: Wang, Yao, et al.
Publicado: (2018)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Repurposing Treprostinil for Enhancing Hematopoietic Progenitor Cell Transplantation
por: Kazemi, Zahra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fhgmosnvi6sdevge4rfq9mc66p